"吸必擴"氣化噴霧劑 160/4.5 微克/劑量

Land: Taiwan

Språk: kinesiska

Källa: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Aktiva substanser:

BUDESONIDE;;FORMOTEROL FUMARATE DIHYDRATE

Tillgänglig från:

臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975)

ATC-kod:

R03AK07

Läkemedelsform:

氣化噴霧劑

Sammansättning:

FORMOTEROL FUMARATE DIHYDRATE (1216003030) ug; BUDESONIDE (8406002100) ug

Enheter i paketet:

鋁罐裝

Klass:

製　劑

Receptbelagda typ:

須由醫師處方使用

Tillverkad av:

ASTRAZENECA DUNKERQUE PRODUCTION 224, AVENUE DE LA DORDOGNE (B.P. 41), 59640 DUNKERQUE CEDEX 2, FRANCE FR

Terapiområde:

formoterol and budesonide

Terapeutiska indikationer:

氣喘(Asthma)Symbicort Rapihaler適用於適合使用吸入型皮質類固醇及長效β2作用劑(β2- agonist)合併治療的氣喘(asthma)常規治療。-以吸入型皮質類固醇和“需要時”吸入短效β2作用劑未能充分控制氣喘的病人慢性阻塞性肺部疾病(COPD)Symbicort Rapihaler適用於患有中至重度COPD，頻繁出現症狀及有惡化病史之病人的常規治療。

Produktsammanfattning:

有效日期: 2026/03/07; 英文品名: Symbicort Rapihaler 160/4.5ug/dose

Tillstånd datum:

2016-03-07

Bipacksedel

160/4.5
/
SYMBICORT RAPIHALER
® 160/4.5 ΜG/DOSE
026657
budesonide 160 µg
formoterol
fumarate dihydrate
4.5 µg
Formoterol fumarate dihydrate
formoterol
pressurized metered-dose inhaler
pMDI
®
Asthma
Symbicort Rapihaler
β
2
β
2
-
agonist
asthma
β
2
®
COPD
Symbicort Rapihaler
COPD
®
Symbicort Rapihaler
Symbicort Rapihaler
/
β
2
Symbicort
Symbicort
Symbicort Rapihaler
2
Symbicort Rapihaler
160
/
4.5 mcg
/
18
2
2
2
4
12-17
2
2
®
COPD
COPD
160
/
4.5 mcg
/
18
2
2
4
Symbicort
budesonide
formoterol
Symbicort Rapihaler
Symbicort Rapihaler
•
•
•
•
10
•
•
•
•
budesonide
formoterol
COPD
Symbicort Rapihaler
Symbicort Rapihaler
Symbicort Rapihaler
Symbicort Rapihaler
Symbicort
Rapihaler
Symbicort Rapihaler
Symbicort Rapihaler
p a r a d o x i c a l
bronchospa
sm
Symbicort
Rapihaler
budesonide
1
400 µg
800 µg
budesonide
Symbicort
Symbicort Rapihaler
budesonide
itraconazole
ritonavir
CYP3A4
CYP3A4
Symbicort Rapihaler
Symbicort Rapihaler
QTc
formoterol
QTc
β
2
xanthine
β
2
β
2
central serous
chorioretinopathy, CSCR
CSCR
COPD
COPD
COPD
COPD
COPD
BMI
COPD
Ketoconazole 200 mg
budesonide 3 mg
6
ketoconazole
budesonide
12
3
budesonide
ketoconazole
budesonide
budesonide
CYP3A4
itraconazole
ritonavir
budesonide
CYP3A4
β
-
formoterol
Symbicort Rapihaler
β
-
quinidine
disopyramide
procainamide
phenothiazines
terfenadine
酶
MAO
QTc
L-Dopa
L-thyroxine
oxytocin
β
2
MAO
furazolidone
procarbazine
hal
ogenated hydrocarbons
β
-
digitalis glycosides
budesonide
formoterol
Symbicort Rapihaler
formoterol
budesonide
formoterol
formoterol
2500
budesonide
Symbicort Rapihaler
budesonide
Budesonide
formoterol
Symbicort
Rapihaler
Symbicort Rapihaler
Symbicort Rapihaler
budesonide
formoterol
β
2
budesonide
formoterol
1
SOC
SOC
≥
1% - < 10%
COPD
≥
0.1% - < 1%
≥
0.01% - < 0.1%
< 0.01%
paradoxical
bronchospasm
β
2
Formoterol
β
2
QT
Budesonide
ATC
R03AK07
Symbicort
formoterol
budesonide
COPD
budesonide
formoterol
Budesonide
Budesonide
glucocorticosteroid
budesonide
Formoterol
Formoterol
β
2
1-3
12
Symbicort Rapihal